• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Bellevue Funds Lux - BB Biotech

+ Add to Watchlist

BBBIOCB:LX

337.41 CHF 2.83 0.85%

As of 08:48:00 ET on 09/19/2014.

Snapshot for Bellevue Funds Lux - BB Biotech (BBBIOCB)

Year To Date: +29.53% 3-Month: +18.66% 3-Year: +43.15% 52-Week Range: 230.09 - 337.41
1-Month: +6.55% 1-Year: +32.46% 5-Year: +18.53% Beta vs LUXXX: 0.68

Mutual Fund Chart for BBBIOCB

No chart data available.
  • BBBIOCB:LX 337.41
  • 1M
  • 1Y
Interactive BBBIOCB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BBBIOCB

Bellevue Funds (Lux) - BB Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector. The focus is on companies that develop, research, and market various technologies and products in this sector.

Inception Date: 04-02-2009 Telephone: 41-44-267-67-00
Managers: DANIEL KOLLER / TAZIO STORNI
Web Site: www.bellevuegroup.com

Fundamentals for BBBIOCB

NAV (on 2014-09-19) 337.41
Assets (M) (on 2014-09-19) 54.44
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for BBBIOCB

No dividends reported

Fees & Expenses for BBBIOCB

Front Load -
Back Load 0.00
Current Mgmt Fee 1.60
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BBBIOCB

Filing Date: 08/29/2014
Name Position Value % of Total
Gilead Sciences Inc 49,526 5,328,007 9.815%
Celgene Corp 54,964 5,222,679 9.620%
Biogen Idec Inc 13,947 4,784,379 8.813%
Amgen Inc 18,766 2,615,605 4.818%
Alexion Pharmaceuticals Inc 15,146 2,564,066 4.723%
Regeneron Pharmaceuticals Inc 6,795 2,381,783 4.387%
Vertex Pharmaceuticals Inc 25,071 2,345,893 4.321%
Incyte Corp 36,352 1,970,278 3.629%
Medivation Inc 19,346 1,765,516 3.252%
Isis Pharmaceuticals Inc 38,893 1,585,279 2.920%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil